STOCK MARKET BSE NSE

DCA to set up unit to monitor sale of drugs

Drug Control Authorities in Telangana and other states might create an intelligence Cell which will closely monitor sale and supply of spurious and expired drugs and other aspects related to medicines. 

Published: 16th June 2017 01:45 AM  |   Last Updated: 16th June 2017 04:58 AM   |  A+A-

By Express News Service

HYDERABAD: Drug Control Authorities in Telangana and other states might create an intelligence Cell which will closely monitor sale and supply of spurious and expired drugs and other aspects related to medicines. 


The Drugs Consultative Committee at its 51st meeting held on June 9 in New Delhi suggested that each State’s Drug Control Authority should create an Intelligence Cell with a Nodal Officer for market surveillance and ‘conducting investigation with respect to spurious and adulterated drugs in coordination with Central Drugs Standard Control Organisation (CDSCO).’


Officials from Telangana Drug Control Administration (DCA) said that nodal officer of the cell will be an official from CDSCO. The Drugs and Cosmetics Rules, 1945, are set to be changed. A new set of rules segregating various aspects such as clinical trials, sale of drugs (at pharmacies and online mode), cosmetics will be framed. 

Stay up to date on all the latest Telangana news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp